Catalyst Wire Dossier Catalyst Wire Dossier

CTAP101

· OPKO IP Holdings II, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CTAP101, covering 2014-09-30 to 2022-12-09. Get the full timeline:

Most recent: Clinical Trial Update: Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency [Phase 4]

See pricing